Showing results (51-60 of 640) with videos related to
Sort By:
Pageof 64
Vaccine|October 13, 2007
Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.Human Gene Therapy|December 28, 2012
Innovative DNA vaccine to break immune tolerance against tumor self-antigenTae Heung Kang, Chih-Ping Mao, Victor La, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesionsShiwen Peng, Cornelia Trimble, Lee Wu, et al.Vaccine|September 24, 2014
Cancer immunotherapy using a potent immunodominant CTL epitopeLiwen Song, Ming-Chieh Yang, Jayne Knoff, et al.Expert Review of Vaccines|February 23, 2016
Current state in the development of candidate therapeutic HPV vaccinesAndrew Yang, Jessica Jeang, Kevin Cheng, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gunDaejin Kim, Talia Hoory, Archana Monie, et al.Vaccine|December 22, 2007
Generation and characterization of a preventive and therapeutic HPV DNA vaccineDaejin Kim, Ratish Gambhira, Balasubramanyam Karanam, et al.Vaccine|November 29, 2011
LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccinesTong Tong Zhang, Tae Heung Kang, Barbara Ma, et al.Vaccine|June 11, 2017
Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor modelYing Ma, Andrew Yang, Shiwen Peng, et al.Human Gene Therapy|December 7, 2010
Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agentsQi Zeng, Shiwen Peng, Archana Monie, et al.Pageof 64